|کد مقاله||کد نشریه||سال انتشار||مقاله انگلیسی||ترجمه فارسی||نسخه تمام متن|
|5665971||1407779||2017||3 صفحه PDF||سفارش دهید||دانلود کنید|
- An overall 96.2% agreement between methods was observed.
- No additional targets were detected by the FilmArray molecular panel.
- Two HSV-1 positive samples were negative by the FilmArray molecular panel.
- More studies are needed to adequately evaluate panel performance for HSV-1.
We compared an FDA cleared molecular meningitis/encephalitis panel to lab developed viral PCRs and bacterial culture. Of the 67 viral PCR or bacterial culture-positive samples, 92.5% were positive for the same target by the panel. Of the 66 negative samples tested, no targets were detected by the panel, for an agreement of 96.2%.
Journal: Diagnostic Microbiology and Infectious Disease - Volume 87, Issue 1, January 2017, Pages 92-94